Hydroxychloroquine suppresses replication of PRRSV via dual regulation of autophagic flux and NF-κB-driven inflammatory signaling
- 1Guangdong Provincial Key Laboratory of Zoonosis Prevention and Control, College of Veterinary Medicine, South China Agricultural University, Guangzhou, 510462 China
- 2National Engineering Research Center for Breeding Swine Industry, South China Agricultural University, Guangzhou, 510642 China
- 3Hangzhou Uben Animal Vaccine Co., Ltd, Hangzhou, 310000 China
Abstract
Porcine reproductive and respiratory syndrome virus (PRRSV) induces excessive autophagy and aberrant nuclear factor kappa-light-chain-enhancer of activated B cell (NF-κB) hyperactivation, triggering severe respiratory and reproductive disorders in pigs and causing massive economic losses to the global swine industry. Hydroxychloroquine sulfate (HCQ), a classic autophagy inhibitor, restricts PRRSV proliferation in vitro; however, its in vivo protective efficacy and dual-targeted molecular mechanisms remain poorly characterized. In this study, intramuscular HCQ administration conferred robust protection against lethal PRRSV infection in piglets: it completely eliminated virus-induced mortality, relieved fever and interstitial pulmonary lesions, and restored normal growth performance. In vitro assays confirmed that HCQ with negligible cytotoxicity within the concentration range of 1–100 μM interferes with multiple stages of PRRSV infection. Combined network pharmacology and cellular functional experiments revealed a dual regulatory mechanism of HCQ against PRRSV: HCQ blocks autophagosome–lysosome fusion to disrupt complete autophagic flux, and suppresses the IκBα-p65 signaling cascade to reduce the secretion of proinflammatory mediators. Dose–response analyses demonstrated that HCQ exerts potent antiviral activity against divergent field PRRSV isolates, porcine epidemic diarrhea virus (PEDV) and swine acute diarrhea syndrome coronavirus (SADS-CoV) within a wide safe therapeutic window, with all broad-spectrum in vitro antiviral activity against diverse swine RNA viruses validated in cell culture models. Collectively, HCQ suppresses PRRSV replication by simultaneously regulating autophagic flux and NF-κB-dependent inflammatory signaling, supporting its repurposing as a promising therapeutic candidate for porcine reproductive and respiratory syndrome (PRRS) control. Although HCQ exhibits broad-spectrum inhibitory activity against divergent PRRSV strains, PEDV, and SADS-CoV in cell culture, all anti-PEDV and anti-SADS-CoV effects are only validated in vitro without in vivo animal verification.
Related
- The E3 ubiquitin ligase IDOL suppresses PRRSV replication by targeting viral Nsp3 for SQSTM1-mediated selective autophagic degradation
- Fiber-2 induces autolysosome dysfunction and impairs autophagic flux to promote FAdV-4 replication
- TRIM23 prevents adenovirus replication by p62-mediated selective autophagic degradation of viral E1A protein
- Low-molecular-weight Ulva lacinulata extract exhibiting anti-inflammatory and pro-autophagic activities in RAW 264.7 macrophages: a promising candidate for the development of active ingredients targeting low-grade inflammation
- Porcine reproductive and respiratory syndrome virus hijacks the non-canonical enzymatic function of PHGDH to arrest autophagic flux for viral replication
BibTeX
@article{ye2026hydroxychloroquine,
title = {{Hydroxychloroquine suppresses replication of PRRSV via dual regulation of autophagic flux and NF-κB-driven inflammatory signaling}},
author = {Ruirui Ye and Pengzhan Yuan and Guoxin Zheng and Bin Kang and Haijun Guo and Yankuo Sun and Guihong Zhang and Heng Wang},
journal = {Veterinary Research},
year = {2026},
month = oct,
doi = {10.1186/s13567-026-01855-2},
url = {https://doi.org/10.1186/s13567-026-01855-2},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Hydroxychloroquine suppresses replication of PRRSV via dual regulation of autophagic flux and NF-κB-driven inflammatory signaling
AU - Ruirui Ye
AU - Pengzhan Yuan
AU - Guoxin Zheng
AU - Bin Kang
AU - Haijun Guo
AU - Yankuo Sun
AU - Guihong Zhang
AU - Heng Wang
PY - 2026
DA - 2026/10/27
JO - Veterinary Research
DO - 10.1186/s13567-026-01855-2
UR - https://doi.org/10.1186/s13567-026-01855-2
AB - Porcine reproductive and respiratory syndrome virus (PRRSV) induces excessive autophagy and aberrant nuclear factor kappa-light-chain-enhancer of activated B cell (NF-κB) hyperactivation, triggering severe respiratory and reproductive disorders in pigs and causing massive economic losses to the global swine industry. Hydroxychloroquine sulfate (HCQ), a classic autophagy inhibitor, restricts PRRSV proliferation in vitro; however, its in vivo protective efficacy and dual-targeted molecular mechanisms remain poorly characterized. In this study, intramuscular HCQ administration conferred robust protection against lethal PRRSV infection in piglets: it completely eliminated virus-induced mortality, relieved fever and interstitial pulmonary lesions, and restored normal growth performance. In vitro assays confirmed that HCQ with negligible cytotoxicity within the concentration range of 1–100 μM interferes with multiple stages of PRRSV infection. Combined network pharmacology and cellular functional experiments revealed a dual regulatory mechanism of HCQ against PRRSV: HCQ blocks autophagosome–lysosome fusion to disrupt complete autophagic flux, and suppresses the IκBα-p65 signaling cascade to reduce the secretion of proinflammatory mediators. Dose–response analyses demonstrated that HCQ exerts potent antiviral activity against divergent field PRRSV isolates, porcine epidemic diarrhea virus (PEDV) and swine acute diarrhea syndrome coronavirus (SADS-CoV) within a wide safe therapeutic window, with all broad-spectrum in vitro antiviral activity against diverse swine RNA viruses validated in cell culture models. Collectively, HCQ suppresses PRRSV replication by simultaneously regulating autophagic flux and NF-κB-dependent inflammatory signaling, supporting its repurposing as a promising therapeutic candidate for porcine reproductive and respiratory syndrome (PRRS) control. Although HCQ exhibits broad-spectrum inhibitory activity against divergent PRRSV strains, PEDV, and SADS-CoV in cell culture, all anti-PEDV and anti-SADS-CoV effects are only validated in vitro without in vivo animal verification.
SN - 0928-4249
SN - 1297-9716
ER -